Yousif Capital Management LLC Sells 2,015 Shares of The Cigna Group (NYSE:CI)

Yousif Capital Management LLC trimmed its position in The Cigna Group (NYSE:CI) by 3.6% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 54,423 shares of the health services provider’s stock after selling 2,015 shares during the period. Yousif Capital Management LLC’s holdings in The Cigna Group were worth $16,297,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of CI. Avestar Capital LLC raised its position in The Cigna Group by 0.8% during the 3rd quarter. Avestar Capital LLC now owns 4,585 shares of the health services provider’s stock worth $1,312,000 after purchasing an additional 35 shares during the last quarter. Eads & Heald Wealth Management raised its position in The Cigna Group by 1.7% during the 3rd quarter. Eads & Heald Wealth Management now owns 2,123 shares of the health services provider’s stock worth $607,000 after purchasing an additional 35 shares during the last quarter. Relyea Zuckerberg Hanson LLC raised its position in The Cigna Group by 3.2% during the 4th quarter. Relyea Zuckerberg Hanson LLC now owns 1,113 shares of the health services provider’s stock worth $333,000 after purchasing an additional 35 shares during the last quarter. Strategic Blueprint LLC raised its position in The Cigna Group by 4.8% during the 3rd quarter. Strategic Blueprint LLC now owns 784 shares of the health services provider’s stock worth $224,000 after purchasing an additional 36 shares during the last quarter. Finally, E&G Advisors LP raised its position in The Cigna Group by 1.8% during the 3rd quarter. E&G Advisors LP now owns 2,137 shares of the health services provider’s stock worth $611,000 after purchasing an additional 37 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of The Cigna Group stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total value of $1,608,446.16. Following the sale, the senior vice president now owns 2,102 shares of the company’s stock, valued at approximately $694,668.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of The Cigna Group stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total value of $1,608,446.16. Following the sale, the senior vice president now owns 2,102 shares of the company’s stock, valued at approximately $694,668.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO David Cordani sold 31,209 shares of The Cigna Group stock in a transaction that occurred on Monday, March 25th. The stock was sold at an average price of $355.17, for a total transaction of $11,084,500.53. Following the completion of the sale, the chief executive officer now directly owns 348,054 shares in the company, valued at approximately $123,618,339.18. The disclosure for this sale can be found here. In the last quarter, insiders have sold 114,144 shares of company stock valued at $39,296,330. 0.70% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

CI has been the subject of a number of recent analyst reports. Barclays initiated coverage on The Cigna Group in a report on Wednesday, March 6th. They set an “overweight” rating and a $393.00 price target for the company. Mizuho raised their target price on The Cigna Group from $360.00 to $370.00 and gave the company a “buy” rating in a research note on Monday, February 5th. Wells Fargo & Company raised their target price on The Cigna Group from $334.00 to $348.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 6th. StockNews.com upgraded The Cigna Group from a “buy” rating to a “strong-buy” rating in a research note on Thursday, March 14th. Finally, Deutsche Bank Aktiengesellschaft upgraded The Cigna Group from a “hold” rating to a “buy” rating and raised their target price for the company from $355.00 to $370.00 in a research note on Thursday, February 1st. Two analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, The Cigna Group currently has a consensus rating of “Buy” and an average target price of $362.14.

The Cigna Group Stock Down 0.0 %

NYSE CI traded down $0.06 during trading hours on Wednesday, hitting $352.59. The company’s stock had a trading volume of 601,696 shares, compared to its average volume of 1,581,153. The Cigna Group has a 52 week low of $240.50 and a 52 week high of $365.71. The company has a market capitalization of $103.08 billion, a PE ratio of 20.26, a price-to-earnings-growth ratio of 1.08 and a beta of 0.56. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.61. The company’s 50-day simple moving average is $349.03 and its two-hundred day simple moving average is $316.84.

The Cigna Group (NYSE:CI) last posted its earnings results on Friday, February 2nd. The health services provider reported $6.79 EPS for the quarter, topping the consensus estimate of $6.54 by $0.25. The Cigna Group had a net margin of 2.64% and a return on equity of 13.59%. The firm had revenue of $51.15 billion for the quarter, compared to analysts’ expectations of $48.91 billion. During the same quarter last year, the firm earned $4.96 EPS. The company’s quarterly revenue was up 11.8% compared to the same quarter last year. Research analysts anticipate that The Cigna Group will post 28.36 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, March 21st. Shareholders of record on Wednesday, March 6th were given a dividend of $1.40 per share. The ex-dividend date was Tuesday, March 5th. This represents a $5.60 annualized dividend and a dividend yield of 1.59%. This is a boost from The Cigna Group’s previous quarterly dividend of $1.23. The Cigna Group’s dividend payout ratio (DPR) is currently 32.20%.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.